These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2450240)

  • 81. The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan.
    Haikala H; Kaheinen P; Levijoki J; Lindén IB
    Cardiovasc Res; 1997 Jun; 34(3):536-46. PubMed ID: 9231037
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 1st communication: studies on isolated guinea pig cardiac muscles.
    Ogawa T; Ohhara H; Tsunoda H; Kuroki J; Shoji T
    Arzneimittelforschung; 1989 Jan; 39(1):33-7. PubMed ID: 2566308
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Potent stimulation of myofilament force and adenosine triphosphatase activity of canine cardiac muscle through a direct enhancement of troponin C Ca++ binding by MCI-154, a novel cardiotonic agent.
    Kitada Y; Kobayashi M; Narimatsu A; Ohizumi Y
    J Pharmacol Exp Ther; 1989 Jul; 250(1):272-7. PubMed ID: 2545860
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Pharmacology of LY195115, a potent, orally active cardiotonic with a long duration of action.
    Hayes JS; Pollock GD; Wilson H; Bowling N; Robertson DW
    J Cardiovasc Pharmacol; 1987 Apr; 9(4):425-34. PubMed ID: 2438505
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Does the positive inotropic action of a novel cardiotonic agent, MCI-154, involve mechanisms other than cyclic AMP?
    Kitada Y; Narimatsu A; Suzuki R; Endoh M; Taira N
    J Pharmacol Exp Ther; 1987 Nov; 243(2):639-45. PubMed ID: 2824754
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Effects of MCI-154, a new cardiotonic Ca2+ sensitizer, on ventricular arrhythmias and membrane ionic currents.
    Eto K; Xue YX; Hashimoto K
    Eur J Pharmacol; 1996 Mar; 298(3):247-56. PubMed ID: 8846823
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Cardiac effects of amrinone on rabbit papillary muscle and guinea pig Langendorff heart preparations.
    Onuaguluchi G; Tanz RD
    J Cardiovasc Pharmacol; 1981; 3(6):1342-55. PubMed ID: 6173535
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effects of dopamine on sinus rate and ventricular contractile force of the dog heart in vitro and in vivo.
    Endoh M
    Br J Pharmacol; 1975 Dec; 55(4):475-86. PubMed ID: 1212559
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Electrophysiological effects of Org 7797 in the closed-chest anaesthetized dog.
    Leboeuf J; Basiez M; Massingham R
    Br J Pharmacol; 1993 Sep; 110(1):23-8. PubMed ID: 8220882
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Inosine : a naturally occurring cardiotonic agent.
    Aviado DM
    J Pharmacol; 1983; 14 Suppl 3():47-71. PubMed ID: 6368998
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The mode of vasoinhibitory action of a pyridazione derivative (MCI-154), a new cardiotonic agent, on contractile responses induced by alpha-adrenoceptor agonists and 45Ca influx in isolated vascular smooth muscles.
    Shibata S; Satake N; Hester RK; Kurahashi K; Ito M
    Eur J Pharmacol; 1988 Jan; 145(2):113-21. PubMed ID: 2895000
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Effect of a calcium-sensitizing positive inotropic agent MCI-154 and its combined use with enalapril on postischemic contractile dysfunction of dog hearts.
    Abe Y; Kitada Y; Narimatsu A
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):653-9. PubMed ID: 8569229
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Effects of quinidine on blood flow rate and developed tension in blood-perfused canine papillary muscle.
    Himori N; Taira N
    Clin Exp Pharmacol Physiol; 1976; 3(1):1-7. PubMed ID: 971549
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Dual effects of a new coronary vasodilator, diltiazem, on the contractile force of the blood-perfused papillary muscle of the dog.
    Himori N; Ono H; Taira N
    Jpn J Pharmacol; 1975 Jun; 25(3):350-2. PubMed ID: 1185907
    [No Abstract]   [Full Text] [Related]  

  • 95. Comparative cardiac toxicity of the i.v. administered benzimidazole pyridazinon derivative Pimobendan and its enantiomers in female Beagle dogs.
    Schneider P; Güttner J; Eckenfels A; Heinzel G; von Nicolai H; Trieb G; Lehmann H
    Exp Toxicol Pathol; 1997 Aug; 49(3-4):217-24. PubMed ID: 9314056
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Novel types of cardiotonic drugs].
    Ohizumi Y
    Nihon Yakurigaku Zasshi; 1992 Sep; 100(3):259-69. PubMed ID: 1398336
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Rational use of vasoactive drugs after cardiac resuscitation: focus on inotropic agents.
    Girbes AR
    Resuscitation; 2000 Nov; 47(3):339-42. PubMed ID: 11114468
    [No Abstract]   [Full Text] [Related]  

  • 98. Quantitative structure-activity relationships of cardiotonic agents.
    Gupta SP
    Prog Drug Res; 2000; 55():235-82. PubMed ID: 11127965
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Pharmacological actions of cardipro on cardiovascular system.
    Chatterjee S; Das SN; Agrawala SK
    Anc Sci Life; 1998 Jul; 18(1):64-77. PubMed ID: 22556872
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [The papillary muscle of the heart of a young dog allows the study of the cardiotonic power of digitalis substances].
    LOUBATIERES A
    C R Seances Soc Biol Fil; 1948 Jun; 142(11-12):793-5. PubMed ID: 18891676
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.